Skip to content

Flourish Vaginal Care System to Establish Neovaginal Microbiome

Pilot Study to Observe Effects of Using Flourish Vaginal Care System to Establish Neovaginal Microbiome After Gender-Confirmation Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05372770
Enrollment
56
Registered
2022-05-13
Start date
2022-01-24
Completion date
2024-12-12
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neovaginal Microbiome

Keywords

neovagina, microbiome, lactobacillus, transgender, probiotic

Brief summary

This study examines whether use of a commercially-available vaginal wellness system is able to establish a microbiome in transgender women.

Detailed description

Very little is known about the neovaginal microbiome, but it has been described as being a polymicrobial state similar to bacterial vaginosis (BV) in cis women. The Flourish Vaginal Care System is a commercially-available over-the-counter vaginal wellness kit that helps relieve symptoms of BV. This study is intended to determine whether that kit could also help transgender women who have recently undergone gender-confirming surgery to establish a neovaginal microbiome that is dominated by lactobacilli, as observed in healthy cis women. This could increase health and subjective satisfaction of the neovagina. This study examines the (neo)vaginal microbiome in transgender women with and without using Flourish, as well as a group of healthy cisgender women.

Interventions

Flourish includes Restore® vaginal moisturizing gel, a Class II medical device cleared by the FDA, in addition to two other kit components

Sponsors

Vaginal Biome Science
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Two groups of transgender women who have undergone surgery plus a group of healthy cisgender women who have not undergone surgery

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Transgender women over age 18 who are preparing to undergo gender-confirmation surgery. 2. Healthy cisgender women ages 18-52

Exclusion criteria

1. Immunosuppressed 2. Known allergies or sensitivities to aloe vera or to other components of Restore®, Balance, or BiopHresh® 3. Known (neo)vaginal infection that is not yeast or BV at start of protocol 4. Inability to tolerate Restore gel by day 13 after surgery.

Design outcomes

Primary

MeasureTime frameDescription
Vaginal microbiomeCollections at time 0, 6 weeks, and 6 monthsObservation of changes in the composition of the vaginal fluid microbiome over six months using commercially available next-generation sequencing kit (16s rRNA). Biomes will be categorized to community state type (Ravel 2011), and genus- or species-level relative abundance will be compared.
Vaginal pHCollections at time 0, 6 weeks, and 6 monthsObservation of changes in vaginal pH over six months by pH strip

Secondary

MeasureTime frameDescription
VSQCollections at time 0, 6 weeks, and 6 monthsResponses to the Vulvovaginal Symptoms Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026